ELV

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for WellPoint, Inc. (now Elevance Health, Inc.) for the period ended June 30, 2008. WellPoint is the largest health benefits company in the United States by medical membership, serving 35.3 million members. The company operates through three reportable segments: Commercial, Consumer, and Other. The report details financial performance, operational results, and liquidity for the three and six months ended June 30, 2008, compared to the same periods in 2007.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total operating revenue increased 3% year-over-year, driven by premium rate increases, growth in Medicare Advantage, and increased reimbursement in the Federal Employee Program (FEP). This was partially offset by the loss of the New York State prescription drug contract and declines in fully-insured membership.
• Profitability Decline: Net income decreased 17% to $1.3 billion. The decline was primarily due to higher medical costs, particularly in the Medicare Advantage and Local Group fully-insured businesses, and net realized investment losses of $73.4 million (compared to a gain of $1.1 million in 2007).
• Benefit Expense: The benefit expense ratio increased 170 basis points to 84.2%. This was driven by higher utilization and adverse selection in Medicare Advantage products and less favorable prior year reserve development in Local Group business.
• Cash Flow: Operating cash flow decreased significantly to $1.1 billion (down from $2.7 billion in 2007). This was due to timing differences in CMS payments, increased receivables from system migrations, and lower net income.
• Investment Losses: The company recorded $197.9 million in other-than-temporary impairment charges for the six months ended June 30, 2008, compared to $107.8 million in the prior year period, reflecting deterioration in equity and fixed maturity markets.

Guidance, Outlook, and Risks

• Medical Cost Trends: Management estimates the 2008 cost of care trend at 8% (plus or minus 50 basis points). Trends are driven by unit costs, particularly inpatient hospital costs (low double digits) and outpatient services (mid-to-upper single digits).
• Medicare Advantage: The company is addressing higher benefit expenses in Medicare Advantage through medical management initiatives for the remainder of 2008 and pricing/benefit design changes for 2009.
• Capital Allocation: The company repurchased approximately 46.5 million shares for $2.88 billion during the first six months of 2008. Approximately $1.4 billion remained authorized for future repurchases as of June 30, 2008.
• Liquidity: The company maintains a strong liquidity position with $19.5 billion in cash, cash equivalents, and investments. It has access to a $2.5 billion commercial paper program and a $2.5 billion senior revolving credit facility.
• Risks: Key risks include escalating health care costs, regulatory changes, litigation (including ongoing California rescission investigations and settlements), and market volatility affecting investment portfolios. The company noted that certain mortgage-backed and asset-backed securities were thinly traded, requiring internal estimates for fair value.

Investor Verification Checklist

• Medical Cost Trend Accuracy: Verify if the 8% cost trend assumption holds given the reported 170 basis point increase in the benefit expense ratio.
• Medicare Advantage Performance: Monitor the effectiveness of medical management initiatives and the impact of benefit design changes on future profitability in the Consumer segment.
• Investment Portfolio Health: Review the composition of Level III fair value measurements and the potential for further other-than-temporary impairment charges given market volatility.
• Receivables Collection: Track the reduction in accounts receivable, which increased due to system migrations and delayed reimbursements, to ensure expected cash flow improvements materialize in the second half of 2008.
• Legal Settlements: Confirm the final terms and financial impact of the California hospital class action settlement and the Department of Managed Health Care investigation regarding rescission practices.